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Bovine mastitis is the most costly disease affecting dairy cows and milk production. As 
Staphylococcus aureus is considered as a major pathogen due to its prevalence in dairy herds, 
contagious nature of infection, economic impact of treatment and control and its resistance to 
antimicrobial agents is a well-documented challenge in dairy cows. Therefore, the purpose of this study 
was to investigate and determine the antibacterial activity of silver nanoparticles against S. aureus 
isolated from subclinical mastitis cows. The minimum inhibitory concentrations (MIC) distribution of the 
silver nanoparticles tested for S. aureus field isolates were determined by a broth dilution method. The 
results show MIC values ranging from 1.25 to 10 µg/ml. The MIC values that inhibited 50 and 90% of the 
population of the isolates tested of silver nanoparticles were 5 and 10 µg/ml for S. aureus, respectively. 
In addition, the results of this study demonstrated that the mean time of the antimicrobial action of 
silver nanoparticles against S. aureus is 7 min.  This in vitro result clearly indicates that the silver 
nanoparticle might have a good activity against S. aureus with mastitis origin. 
 





Bovine mastitis is the most costly disease affecting dairy 
cows and milk production. This disease is one of the 
major causes of antibiotic use in dairy cows (Mitchell et 
al., 1998). Staphylococcus aureus is considered as a 
major mastitis pathogen due to its prevalence in dairy 
herds, contagious nature of infection and economic 
impact of treatment and control (Bradley, 2002). Its 
resistance to antimicrobial agents is a well-documented 
challenge in dairy cows. Because of resistance to 
antimicrobial agents in mastitis pathogens, there is a 
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Abbreviations: CMT, California mastitis test; MIC, minimal 
inhibitory concentration; TSB, trypticase soy broth; MBC, 
minimal bactericidal concentration; DNA, deoxyribonucleic acid. 
Silver is one of the non-toxic and safe antibacterial 
agents to the body, and can kill many harmful 
microorganisms (Dowling et al., 2003). It has been known 
since ancient times that silver and its compounds are 
effective antimicrobial agents. In particular, due to the 
recent advances in research on metal nanoparticles, 
silver nanoparticles have received special attention as a 
possible antimicrobial agent. When certain particles are 
very small size, nanosize, the number of particles may be 
increased in unit area. The total surface area of the 
nanosized silver particles is larger than that of large-sized 
silver in identity volume, then antibacterial ability of the 
nanosized silver particles is more effective than the large-
sized silver (Yeo et al., 2003). Referring to the existing 
scientific literature, no data have been published in the 
onset time of the antimicrobial action of silver 
nanoparticles. Therefore, the objective of the present 
study was to investigate the antibacterial activity of silver 
nanoparticles against S. aureus  isolated from subclinical.  




Table 1. Determination of MIC, susceptibility and onset time of action of the silver nanoparticle against S. aureus (n = 7) 













nanoparticle 0.039-160 1.25-10 5 10 100 3-10 7 
 
1Dilution range, MIC range, MIC50 and MIC90 (in µg/ml); 2, % of sensitive isolates; 3, average and mean of onset time of action 












Nanosilver particles colloidal solution (Cat. No: PL-Ag-S10-10mg) 
was purchased from PlasmaChem GmbH, Germany. The average 





Subclinical mastitis cows were defined as California mastitis test 
(CMT) positive (2+ or more) but absence of clinical signs of mastitis 
(Karimuribo et al., 2005). Milk samples were aseptically collected 
from each quarter of 50 cows with subclinical mastitis, briefly, 
immediately after the pre-milk hand-stripping, teat orifices were 
scrubbed with a cotton pledget saturated in 70% ethyl alcohol. 
Primary isolates were from milk samples that were streaked onto 
5% sheep blood agar plates using a sterile cotton swab and 
incubated at 37°C for 18 to 24 h. Colony morphology, gram staining 
and catalase test were used to identify bacterial genus. The 
colonies identified as S. were submitted to coagulase test using 
rabbit plasma. The examinations were followed by examining the 
susceptibility profile of isolates towards bacitracin. The tests of 
sucrose, D-mannose, D-manitol, maltose, D-trehalose, raffinose 
fermentation, urease activity and acetoin production were also 
assayed. All tests were performed as described by Quinn et al. 
(1994). After identification, 7 isolates of S. aureus were inoculated 
in trypticase soy broth (TSB), and incubated at 37°C for 24 h. The 
bacterial concentration of TSB was estimated to be 3×108 cfu per ml 
using serial dilution method. 
 
 
Determination of the minimum inhibitory concentrations (MIC) 
and minimal bactericidal concentration (MBC) 
 
The MIC determinations of the silver nanoparticles for S. aureus 
field isolates were performed using the serial dilution method. The 
dilutions tested were 0.0195 to 160 g/mL. The MIC was 
determined after 24 h of incubation at 37°C. The first dilution with 
no visible growth was considered as the MIC for each isolate. The 
concentration of the silver nanoparticles able to inhibit the visible 
growth of 50% of a population of microorganisms (MIC50) and the 
concentration of the silver nanoparticles able to inhibit the visible 
growth of 90% of a population of microorganisms (MIC90) were 
calculated for S. aureus field isolates as well as the minimum and 
maximum MIC (Table 1). 
Determination of the onset of the action of nanosilver particles 
 
To examine the onset of the action of nanosilver particles, 0.1 ml of  
TSB media containing 3×108 cfu/ml from each isolate were 
inoculated into 12 sterile tubes each containing 20 ml of TSB plus 
10 µg/ml nanosilver particles (the concentration of nanosilver 
particles used in this experiment was the same as MIC90 obtained in 
the previous experiment). The media were incubated at 37°C for 0, 
1, 3, 7, 10, 15, 30, 45, 60, 120, 180 and 240 min (for tubes no. 1 to 
12, respectively). Using a sterile swab, samples from these tubes 
were sub-cultured onto plates containing 8 ml of Blood agar and 
incubated at 37°C for 72 h. The study was repeated twice. 
 
 
RESULTS AND DISCUSSION 
 
Based on the results of CMT, 50 cows were diagnosed 
with subclinical mastitis. Then the samples of milk cows 
were cultured on the blood agar media and colonies 
suspected to S. aureus were selected. Characteristics 
such as white, opaque colonies and positive coagulase, 
catalase, hemolysis, mannitol fermentation, fermentation 
of maltose and VP as well as growth on the specific 
media such as Baird Parker (black colonies) and obser-
vation of  Gram positive clusters colonies in Gram 
staining examination confirmed our diagnosis of 7 S. 
aureus isolates. Many investigators have used the same 
methods to identify, separation and purification of S. 
aureus (Nunes et al., 2007; Schneider et al., 2004). 
The present study is the first one to evaluate the effect 
of silver nanoparticles on S. aureus isolated from subcli-
nical mastitis. Using serial dilution method, the MIC distri-
bution and MIC50 and MIC90 values (MIC that inhibited 50 
and 90% of the isolates tested, respectively) of the silver 
nanoparticles for S. aureus field isolates are summarized 
in Table 1. MICs being in the range of 1.25-10 µg/ml with 
a MIC90 of 10 µg/ml. All isolates were susceptible to silver 
nanoparticles. None of the isolates were considered 
tolerant as assessed by the general rule that tolerance is 
indicated if the sum of the MIC is greater than 32. 
The results of the study performed to determination of 
the onset time of the antimicrobial action of silver nano-
particles are demonstrated in Table 1. The range of the 
onset time was 3-10 min and its mean was approximately 
7 min.  
The  result  of  the   present  study  showed  that  nano- 





approximately 7 min are able to kill S. aureus isolates. In  
agreement with the results of the present study, it has 
been reported by other investigators that nanoparticles of 
silver have antibacterial effects (Grier, 1983). Lee et al. 
(2003) reported that nanosilver particles in colloidal 
solution at a concentration of 5 ppm have excellent 
antibacterial effect against S. aureus and Klebsiella 
pneumonia. Cho et al. (2005) reported also that the MIC 
of silver nanoparticles against S. aureus is 5ppm. 
However, due to the use of: different methods of 
production, different nanoparticles size, and different 
nanoparticles shape, many products commonly 
summarized under the name nanoparticles can be 
physically and chemically completely different 
preparations  (Pal et al., 2007). Depending on these 
factors, nanoparticles can have highly variable 
antibacterial properties (Merisko-Liversidge et al., 2003), 
which result in controversial results. Pal et al. (2007) 
reported that the MIC of silver nanoparticles against 
Escherichia coli is 12.5 g/mL. Furthermore, it has been 
reported by Ugur and Ceylan (2003) that MIC for silver 
nitrate against S. aureous is in the range of 8-80 g/ml.  
To author’s knowledge, there is no study investigating 
the onset time of antibacterial activity of nanosilver 
particles. The mechanism of bactericidal action of silver 
nanoparticles is still not well understood. However, it was 
shown that the interaction between silver nanoparticles 
and constituents of the bacterial membrane caused 
structural changes in and damage to membranes, finally 
leading to cell death (Grier, 1983). 
Pal et al. (2007) speculated that the action of silver 
nanoparticles is broadly similar to that of silver ion. It 
reacts with the thiol group and inhibits respiratory 
enzymes, facilitating the generation of reactive oxygen 
species and consequently damaging the cell.  
Silver nanoparticles have also intensive tendency to 
react with sulfur and phosphorus groups. Thus, the cell 
membrane proteins containing sulfur and compounds 
containing phosphorus such as deoxyribonucleic acid 
(DNA) are likely to be the preferential sites for silver 
nanoparticle (McDonnell and Russell, 1999). Based on 
result obtained in this study and from literature review, it 
can be concluded that antibacterial activity of 
nanoparticles of silver commerce relatively soon after 
inoculation of S. aureus. Furthermore, using nanosilver 
particles as an alternative to antibiotics in subclinical 
mastitis can be considered. Further work should be 
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